Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Colorectal Neoplasms 6Prostatic Neoplasms 5Ovarian Neoplasms 5Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Brain Neoplasms 3Urogenital Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms, Unknown Primary 2Hereditary Breast and Ovarian Cancer Syndrome 2Head and Neck Neoplasms 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1

Interventions

Metformin 149Clomiphene 50Letrozole 38Inositol 34Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Genetic Testing × Clear all
NCT07412028 2026-02-17

ANDROLIPO

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting
81 enrolled

Polycystic Ovary Syndrome, Lipodystrophy, Familial Partial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡